Galapagos N.V. (NASDAQ:GLPG) Q3 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Galapagos Third Quarter 2025 Financial Results Conference Call.
Galapagos Nv (GLPG)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Madison Avenue Partners Eli Samaha | 2,213,169 | $72,370,626 | +1% | 3.11% |
| 2. | EcoR1 Capital Oleg Nodelman | 1,667,119 | $54,514,791 | 2.47% | |
| 3. | Prosight Capital Lawrence Hawkins | 1,074,112 | $35,123,462 | -7% | 7.26% |
| 4. | Renaissance Technologies Jim Simons | 310,600 | $10,156,620 | -13% | 0.02% |
| 5. | Hudson Bay Capital Management Sander Gerber | 170,000 | $5,559,000 | -31% | 0.02% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 16,707,477 | $550,616,290 | 28.45% | |
| 2. | 448,096 | $14,652,739 | 0.2% | |
| 3. | 349,444 | $11,426,819 | 0% | |
| 4. | 314,269 | $10,276,596 | 0% | |
| 5. | 90,000 | $2,943,000 | 0% |
News See All
Galapagos NV (GLPG)’ CAR-T Therapy Hits 97% Response Rate in Lymphoma Trial
Galapagos NV (NASDAQ:GLPG) is a Belgian-based firm and is carving out a leading position in next-generation oncology through its CAR-T programs and decentralized manufacturing model, designed to deliver...
11 Best Performing Biotech Stocks So Far in 2025
On July 8, Jared Holz of Mizuho spoke on CNBC's "Closing Bell Overtime" about whether the biotech sector is ready for a breakthrough.
Galapagos NV (NASDAQ:GLPG) Q1 2025 Earnings Call Transcript
Operator: Good day! And thank you for standing by. Welcome to the Galapagos First Quarter 2025 Financial Results and Business Update. At this time all participants are in a listener-only mode.
Top 9 Healthcare Stocks to Buy According to Billionaire David Einhorn
Wall Street has come down crashing on President Donald Trump’s sweeping tariffs, raising the risk of a trade war that could push the global economy into recession.
10 Cheap Biotech Stocks to Invest in Now
Biotechnology stocks are among the most volatile in the market due to their high risk.
Galapagos NV (NASDAQ:GLPG) Q3 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Galapagos Q3 2024 Financial Results Audio Webcast. At this time, all participants are in a listen-only mode.
Galapagos NV (NASDAQ:GLPG) Q2 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Galapagos First Half 2024 Financial Results Conference Call. At this time, all participants are in listen-only mode.
Galapagos NV (NASDAQ:GLPG) Q1 2024 Earnings Call Transcript
Sofie Van Gijsel: Welcome all to the audio webcast of Galapagos' Q1 2024 Results. I'm Sofie Van Gijsel, Investor Relations representing the reporting team at Galapagos.
11 Oversold Biotech Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold biotech stocks to buy right now.
Hedge Fund Resource Center Billionaire Hedge Funds
